Zinc and immunity: An essential interrelation

Archives of Biochemistry and Biophysics

Volumn 611, Issue , 2016, Pages 58-65

  Maares, Maria ^a   Haase, Hajo ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Adaptive immunity; Cytokines; Immune system; Innate immunity; Zinc

Indexed keywords

ZINC; TRACE ELEMENT;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; DENDRITIC CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; CHEMISTRY; CYTOLOGY; DIETARY SUPPLEMENT; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; PHAGOCYTOSIS; RESPIRATORY BURST;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; DENDRITIC CELLS; DIETARY SUPPLEMENTS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION; KILLER CELLS, NATURAL; LYMPHOCYTES; MACROPHAGES; MICRONUTRIENTS; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; ZINC;

EID: 84962120865     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2016.03.022     Document Type: Article

References (112)

1. [1] Prasad, A.S., et al. Serum thymulin in human zinc deficiency. J. Clin. Invest. 82:4 (1988), 1202–1210.
2. [2] King, L.E., et al. Chronic zinc deficiency in mice disrupted T cell lymphopoiesis and erythropoiesis while B Cell lymphopoiesis and myelopoiesis were maintained. J. Am. Coll. Nutr. 24:6 (2005), 494–502.
3. [3] Halsted, J.A., Prasad, A.S., Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Trans. Am. Clin. Climatol. Assoc. 72 (1961), 130–149.
4. [4] von Bulow, V., et al. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B. J. Immunol. 179:6 (2007), 4180–4186.
5. [5] Prasad, A.S., et al. Zinc activates NF-kappaB in HUT-78 cells. J. Lab. Clin. Med. 138:4 (2001), 250–256.
6. [6] Haase, H., Rink, L., Zinc signals and immune function. Biofactors 40:1 (2014), 27–40.
7. [7] Haase, H., et al. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J. Immunol. 181:9 (2008), 6491–6502.
8. [8] Miyai, T., et al. Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development. Proc. Natl. Acad. Sci. U. S. A. 111:32 (2014), 11780–11785.
9. [9] Haase, H., Mocchegiani, E., Rink, L., Correlation between zinc status and immune function in the elderly. Biogerontology 7 (2006), 421–428.
10. [10] Ford, D., Intestinal and placental zinc transport pathways. Proc. Nutr. Soc. 63:1 (2004), 21–29.
11. [11] Fraker, P.J., et al. The dynamic link between the integrity of the immune system and zinc status. J. Nutr. 130:5S Suppl (2000), 1399s–1406s.
12. [12] Wapnir, R.A., Zinc deficiency, malnutrition and the gastrointestinal tract. J. Nutr. 130 (2000), 13885–13925.
13. [13] Bonomini, M., et al. Effects of zinc supplementation in chronic haemodialysis patients. Nephrol. Dial. Transpl. 8:10 (1993), 1166–1168.
14. [14] Maret, W., Sandstead, H.H., Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 20:1 (2006), 3–18.
15. [15] Maggini, S., Beveridge, S., Suter, M., A Combination of high-dose vitamin C plus zinc for the common cold. J. Int. Med. Res. 40:1 (2012), 28–42.
16. [16] Rosenkranz, E., et al. Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects. Eur. J. Nutr., 2015, 10.1007/s00394-015-1100-1.
17. [17] Driessen, C., et al. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 84:2 (1995), 272–277.
18. [18] Wellinghausen, N., Kirchner, H., Rink, L., The immunobiology of zinc. Immunol. Today 18 (1997), 519–521.
19. [19] Overbeck, S., Rink, L., Haase, H., Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch. Immunol. Ther. Exp. Warsz. 56:1 (2008), 15–30.
20. [20] Gibson, R.S., et al. Indicators of zinc status at the population level: a review of the evidence. Br. J. Nutr. 99:Suppl 3 (2008), S14–S23.
21. [21] Mayer, L.S., et al. Differential impact of zinc deficiency on phagocytosis, oxidative burst, and production of pro-inflammatory cytokines by human monocytes. Metallomics 6:7 (2014), 1288–1295.
22. [22] Vivier, E., et al. Innate or adaptive immunity? The example of natural killer cells. Science 331:6013 (2011), 44–49.
23. [23] Belardelli, F., Ferrantini, M., Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23:4 (2002), 201–208.
24. [24] Siebenlist, U., Franzoso, G., Brown, K., Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10 (1994), 405–455.
25. [25] Rosenkranz, E., Prasad, A., Rink, L., Immunobiology and Hematology of Zinc. 2011.
26. [26] Sohnle, P.G., et al. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 182:4 (2000), 1272–1275.
27. [27] Schröder, A.K., et al. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunology 119:3 (2006), 317–327.
28. [28] Amulic, B., et al. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30 (2012), 459–489.
29. [29] Lloyd, A.R., Oppenheim, J.J., Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13:5 (1992), 169–172.
30. [30] Lee, W.L., Harrison, R.E., Grinstein, S., Phagocytosis by neutrophils. Microbes Infect. 5:14 (2003), 1299–1306.
31. [31] Hasan, R., Rink, L., Haase, H., Zinc signals in neutrophil granulocytes are required for the formation of neutrophil extracellular traps. Innate Immun. 19:3 (2012), 253–264.
32. [32] Hasegawa, H., et al. Effects of zinc on the reactive oxygen species generating capacity of human neutrophils and on the serum opsonic activity in vitro. Luminescence 15:5 (2000), 321–327.
33. [33] Wessels, I., et al. Zinc deficiency induces production of the proinflammatory cytokines IL-1beta and TNFalpha in promyeloid cells via epigenetic and redox-dependent mechanisms. J. Nutr. Biochem. 24:1 (2013), 289–297.
34. [34] Prasad, A.S., et al. Antioxidant effect of zinc in humans. Free Radic. Biol. Med. 37:8 (2004), 1182–1190.
35. [35] Maret, W., Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal 8:9–10 (2006), 1419–1441.
36. [36] Prasad, A.S., Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front. Nutr., 2014, 1.
37. [37] Keen, C.L., Gershwin, M.E., Zinc deficiency and immune function. Annu. Rev. Nutr. 10 (1990), 415–431.
38. [38] Allen, J.I., et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J. Lab. Clin. Med. 102:4 (1983), 577–589.
39. [39] Hasan, R., Rink, L., Haase, H., Chelation of free Zn Impairs chemotaxis, phagocytosis, oxidative burst, degranulation, and cytokine production by neutrophil granulocytes. Biol. Trace Elem. Res., 2015, 10.1007/s12011-015-0515-0.
40. [40] Hujanen, E.S., Seppa, S.T., Virtanen, K., Polymorphonuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim. Biophys. Acta 1245:2 (1995), 145–152.
41. [41] Prasad, A.S., Zinc: role in immunity, oxidative stress and chronic inflammation. Curr. Opin. Clin. Nutr. Metab. Care 12:6 (2009), 646–652.
42. [42] Dubben, S., et al. Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha,25-dihydroxyvitamin D3. J. Leukoc. Biol. 87:5 (2010), 833–844.
43. [43] Prasad, A.S., Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 182:Suppl 1 (2000), S62–S68.
44. [44] Agnello, D., et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23:3 (2003), 147–161.
45. [45] Bao, B., et al. Intracellular free zinc up-regulates IFN-gamma and T-bet essential for Th1 differentiation in Con-A stimulated HUT-78 cells. Biochem. Biophys. Res. Commun. 407:4 (2011), 703–707.
46. [46] Langrish, C.L., et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202 (2004), 96–105.
47. [47] Bao, B., et al. Zinc modulates mRNA levels of cytokines. Am. J. Physiol. Endocrinol. Metab. 285 (2003), E1095–E1102.
48. [48] Wellinghausen, N., Driessen, C., Rink, L., Stimulation of human peripheral blood mononuclear cells by zinc and related cations. Cytokine 8:10 (1996), 767–771.
49. [49] Wellinghausen, N., Martin, M., Rink, L., Zinc inhibits interleukin-1-dependent T cell stimulation. Eur. J. Immunol. 27:10 (1997), 2529–2535.
50. [50] Driessen, C., et al. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 13:1 (1994), 15–20.
51. [51] Driessen, C., et al. Divergent effects of zinc on different bacterial pathogenic agents. J. Infect. Dis. 171:2 (1995), 486–489.
52. [52] von Bulow, V., Rink, L., Haase, H., Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate. J. Immunol. 175:7 (2005), 4697–4705.
53. [53] Prasad, A.S., et al. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-kappaB. Nutrition 27:7–8 (2010), 816–823.
54. [54] Summersgill, H., et al. Zinc depletion regulates the processing and secretion of IL-1|[beta]. Cell Death Dis., 5(1), 2014.
55. [55] Fraker, P.J., King, L.E., Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 24 (2004), 277–298.
56. [56] Brieger, A., Rink, L., Haase, H., Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions. J. Immunol. 191:4 (2013), 1808–1817.
57. [57] Bao, B., et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am. J. Clin. Nutr. 91:6 (2010), 1634–1641.
58. [58] Yokoyama, W.M., Plougastel, B.F.M., Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:4 (2003), 304–316.
59. [59] Tapazoglou, E., et al. Decreased natural killer cell activity in patients with zinc deficiency with sickle cell disease. J. Lab. Clin. Med. 105 (1985), 19–22.
60. [60] Prasad, A., Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J. Infect. Dis. 2182:Suppl 1 (2000), 62–68.
61. [61] Metz, C.H., et al. T-helper type 1 cytokine release is enhanced by in vitro zinc supplementation due to increased natural killer cells. Nutrition 23:2 (2006), 157–163.
62. [62] Mariani, E., et al. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Exp. Gerontol. 43:5 (2008), 462–471.
63. [63] Kao, I.T., et al. Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells. Stem Cells Dev. 16:6 (2007), 1043–1051.
64. [64] Muzzioli, M., et al. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor. Int. J. Biochem. Cell Biol. 39:5 (2007), 955–965.
65. [65] Vales-Gomez, M., et al. The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins. Immunology 96 (2000), 1734–1739.
66. [66] Rajagopalan, S., et al. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J. Immunol. 155:9 (1995), 4143–4146.
67. [67] Granucci, F., et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:9 (2001), 882–888.
68. [68] Langenkamp, A., et al. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:4 (2001), 311–316.
69. [69] Macatonia, S.E., et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154:10 (1995), 5071–5079.
70. [70] Sarhan, D., et al. Dendritic cell regulation of NK-cell responses involves lymphotoxin-alpha, IL-12, and TGF-beta. Eur. J. Immunol. 45:6 (2015), 1783–1793.
71. [71] Mellman, I., Steinman, R.M., Dendritic cells: specialized and regulated antigen processing machines. Cell 106:3 (2001), 255–258.
72. [72] Kitamura, H., et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol. 7:9 (2006), 971–977.
73. [73] Chow, A., et al. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418:6901 (2002), 988–994.
74. [74] Hardy, R.R., Hayakawa, K., B cell development pathways. Annu. Rev. Immunol. 19 (2001), 595–621.
75. [75] Cantrell, D., T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:1 (1996), 259–274.
76. [76] Fraker, P.J., King, L.E., A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc. Faseb J. 15:14 (2001), 2572–2578.
77. [77] Mosmann, T.R., Coffman, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989), 145–173.
78. [78] Prasad, A.S., Zinc: mechanisms of host defense. J. Nutr. 137:5 (2007), 1345–1349.
79. [79] Oleske, J.M., et al. Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Its correction. Am. J. Dis. Child. 133:9 (1979), 915–918.
80. [80] Golden, M.N., Jackson, A., Golden, B., Effect of zinc on thymus of recently malnourished children. Lancet 310:8047 (1977), 1057–1059.
81. [81] Dowd, P.S., Kelleher, J., Guillou, P.J., T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br. J. Nutr. 55:1 (1986), 59–69.
82. [82] DePasquale-Jardieu, P., Fraker, P., Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J. Immunol. 124 (1980), 2650–2655.
83. [83] King, L.E., Osati-Ashtiani, F., Fraker, P.J., Apoptosis plays a distinct role in the loss of precursor lymphocytes during zinc deficiency in mice. J. Nutr. 132:5 (2002), 974–979.
84. [84] Dardenne, M., et al. In vivo and in vitro studies of thymulin in marginally zinc-deficient mice. Eur. J. Immunol. 14 (1984), 454–458.
85. [85] Haddad, J.J., Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. Mol. Immunol. 47:2–3 (2009), 205–214.
86. [86] Safieh-Garabedian, B., et al. Thymulin modulates cytokine release by peripheral blood mononuclear cells: a comparison between healthy volunteers and patients with systemic lupus erythematosus. Int. Arch. Allergy Immunol. 101:2 (1993), 126–131.
87. [87] Dardenne, M., Zinc and immune function. Eur. J. Clin. Nutr. 56:Suppl 3 (2002), S20–S23.
88. [88] Rothermel, A.L., Gilbert, K.M., Weigle, W.O., Differential abilities of Th1 and Th2 to induce polyclonal B cell proliferation. Cell Immunol. 135:1 (1991), 1–15.
89. [89] Gruber, K., et al. Zinc deficiency adversely influences interleukin-4 and interleukin-6 signaling. J. Biol. Regul. Homeost. Agents 27:3 (2013), 661–671.
90. [90] Beck, F.W., et al. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am. J. Physiol. 272:6 Pt 1 (1997), E1002–E1007.
91. [91] Elser, B., et al. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity 17:6 (2002), 703–712.
92. [92] Prasad, A.S., Zinc in human health: effect of zinc on immune cells. Mol. Med. 14:5–6 (2008), 353–357.
93. [93] Espinoza-Delgado, I., et al. Interleukin-2 and human monocyte activation. J. Leukoc. Biol. 57:1 (1995), 13–19.
94. [94] Bao, B., et al. Toxic effect of zinc on NF-kappaB, IL-2, IL-2 receptor alpha, and TNF-alpha in HUT-78 (Th(0)) cells. Toxicol. Lett. 166:3 (2006), 222–228.
95. [95] Hawrylowicz, C.M., O'Garra, A., Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 5:4 (2005), 271–283.
96. [96] Faber, C., et al. Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response. Bone Marrow Transpl. 33:12 (2004), 1241–1246.
97. [97] Kitabayashi, C., et al. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int. Immunol. 22:5 (2010), 375–386.
98. [98] Varin, A., et al. In vitro and in vivo effects of zinc on cytokine signalling in human T cells. Exp. Gerontol. 43:5 (2008), 472–482.
99. [99] Rosenkranz, E., et al. Zinc Supplementation Induces Regulatory T Cells by Inhibition of Sirt-1 Deacetylase in Mixed Lymphocyte Cultures. 2016.
100. [100] Campo, C.A., et al. Zinc inhibits the mixed lymphocyte culture. Biol. Trace Elem. Res. 79:1 (2001), 15–22.
101. [101] Ouyang, W., Kolls, J.K., Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:4 (2008), 454–467.
102. [102] Afzali, B., et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148:1 (2007), 32–46.
103. [103] Rosenkranz, E., et al. Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration. J. Nutr. Biochem. 29 (2016), 116–123.
104. [104] Bhatnagar, S., et al. Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial. Lancet 379:9831 (2012), 2072–2078.
105. [105] Fraker, P.J., et al. Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review. J. Am. Coll. Nutr. 14:1 (1995), 11–17.
106. [106] Hojyo, S., et al. Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proc. Natl. Acad. Sci. U. S. A. 111:32 (2014), 11786–11791.
107. [107] Strand, T.A., et al. Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice. Infect. Immun. 71:4 (2003), 2009–2013.
108. [108] Zhao, N., et al. Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice. PLoS One, 8(9), 2013, e73461.
109. [109] Duchateau, J., et al. Beneficial effects of oral zinc supplementation on the immune response of old people. Am. J. Med. 70:5 (1981), 1001–1004.
110. [110] Albert, M.J., et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J. Infect. Dis. 187:6 (2003), 909–913.
111. [111] Braga, C.B., et al. Effect of zinc supplementation on serological response to vaccination against streptococcus pneumoniae in patients undergoing chemotherapy for colorectal cancer. Nutr. Cancer 67:6 (2015), 926–932.
112. [112] Sundaram, M.E., et al. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study. Nutr. Res. 34:2 (2014), 149–154.